Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

07ACE25DF18723CC87258B0E00836397 Hearing Summary


Date Apr 29, 2024      
Location Old State Library

SB24-203 - Referred to the Committee of the Whole

05:55:08 PM  
The primary bill
sponsors, Representatives Hartsook and Ortiz, introduced Senate Bill 24-203
to the House Health and Human Services Committee. When determining whether
to conduct an affordability review for a prescription drug, the bill requires
the Colorado Prescription Drug Affordability Review Board (PDAB) to consider
whether the prescription drug has an approved orphan drug designation for
one or more rare diseases and no other indications. If so, the PDAB must
also consider input from consumers and the Colorado Rare Disease Advisory
Council in the Colorado Department of Public Health and Environment.
06:00:18 PM  
The primary bill
sponsors, Representatives Hartsook and Ortiz, provided closing comments
on Senate Bill 24-203.
06:01:28 PM  
Members of the committee provided closing comments on the bill.

06:02:30 PM
Motion Refer Senate Bill 24-203 to the Committee of the Whole.
Moved Ortiz
Seconded Lieder
Bradfield Yes
Bradley Yes
Brown Yes
English Excused
Hamrick Yes
Hernandez Yes
Holtorf Yes
Lieder Yes
Luck Yes
McCormick Yes
Ortiz Yes
Young Yes
Daugherty Yes
Final YES: 12   NO: 0   EXC: 1   ABS:  0   FINAL ACTION:  PASS

The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details